/ /

  • linkedin
  • Increase Font
  • Sharebar

    How new ‘evolving’ IOL formula maximizes lens accuracy


    Real-life examples

    The Ladas Super Formula automatically eliminates the surgeon’s need to mull over the various formulas or adjustments. It relies on peer-reviewed literature to incorporate the needed formulae and adjustments to reach the best-to-date results, and localizes to the correct region on the Ladas Super Surface for every individual patient. Any previously described formula and any future formula can be incorporated into the algorithm.

    Figure 2A: The Ladas Super Formula Interface. An example with a short eye

    Figure 2B: An example with a standard eye.Figure 2C: An example with a somewhat long eye

    Examples of the Ladas Super Formula in action are shown in Figures 2A, 2B, and 2C with a variety of eyes that a surgeon might come across on a daily basis.

    Figure 2A shows the formula performing with a relatively short eye. The Ladas Super Formula recognizes that the patient has a short eye, and decides to choose the appropriate formulae and adjustments to yield the most accurate result.

    Figure 2B is a similar example but showcases a more generic eye that resembles eyes many surgeons encounter in their operating rooms on a daily basis.

    Figure 2C showcases a slightly longer eye. The Ladas Super Formula sees these eyes and decides to incorporate necessary adjustments the formulae need to calculate the most accurate result.

    The Ladas Super Formula can be accessed free of charge at www.iolcalc.com where it is in beta testing. Surgeons are able to perform lens calculations for their patients and provide postoperative data to further hone the accuracy of the formula.

    Comparing formulae

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results